Startseite › Metastasierender Krebs › Missouri › St. Louis
Klinische Studien zu Metastasierender Krebs in St. Louis, MO
54 Studien zu Metastasierender Krebs suchen Teilnehmer an Standorten in und um St. Louis (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- und 6 weitere
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University Medicine, St Louis
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Teilnehmer gesuchtPhase 1/2
- Washington University in St. Louis, St Louis
A Study of ASP3082 in Adults With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Teilnehmer gesuchtPhase 2/3
- Siteman Cancer Center, St Louis
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Teilnehmer gesuchtPhase 3
- Research Site, St Louis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Washington University School of Medicine- Siteman Cancer Center, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Teilnehmer gesuchtPhase 1/2
- Washington University School of Medicine in St. Louis, St Louis
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Teilnehmer gesuchtPhase 2/3
- Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon, O'Fallon · 16 mi entfernt
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Teilnehmer gesuchtPhase 1/2
- Washington University School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
SLV-154 Treatment of Advanced Cancers
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Teilnehmer gesuchtPhase 3
- Washington University School of Medicine, St Louis
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Teilnehmer gesuchtPhase 2
- Siteman Cancer Center (Washington University School of Medicine), St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Teilnehmer gesuchtPhase 1/2
- Washington University, St Louis
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Teilnehmer gesuchtPhase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- und 5 weitere
A Study of KK2269 in Adult Participants With Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Teilnehmer gesuchtPhase 1
- Siteman Cancer Center at Washington University, St Louis
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Teilnehmer gesuchtPhase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- und 1 weitere
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Teilnehmer gesuchtPhase 1
- Washington University in St. Louis, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Washington University, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Investigative Site #110, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Investigative Site #110, St Louis
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Washington University, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
A Study of PYX-201 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Teilnehmer gesuchtPhase 3
- University of Kansas Cancer Center - Overland Park, Overland · 10 mi entfernt
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Exelixis Clinical Site #6, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
REMASTer: REcurrent Brain Metastases After SRS Trial
Teilnehmer gesucht
- WashU, St Louis
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Teilnehmer gesuchtPhase 3
- Washington University, St Louis
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Teilnehmer gesuchtPhase 2
- VA St. Louis Health Care System, St Louis
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Research Site, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Teilnehmer gesuchtPhase 1
- Research Site, St Louis
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Teilnehmer gesuchtPhase 1/2
- Washington University School of Medicine Siteman Cancer Center, St Louis
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Teilnehmer gesuchtPhase 3
- Washington University School of Medicine in Saint Louis, St Louis
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University School of Medicine, St Louis
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Teilnehmer gesuchtPhase 2/3
- Washington University School of Medicine in St. Louis, St Louis
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Teilnehmer gesuchtPhase 3
- Siteman Cancer Center - Washington University, St Louis
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Teilnehmer gesuchtPhase 1
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Washington University, St Louis
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Teilnehmer gesuchtPhase 3
- The Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Washington University Medical Campus, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, St Louis
Metastasierender Krebs-Studien in anderen Städten
- Houston, TX104 Studien
- New York City, NY93 Studien
- Nashville, TN70 Studien
- Boston, MA63 Studien
- Los Angeles, CA57 Studien
- Arlington, VA53 Studien
- Philadelphia, PA46 Studien
- Chicago, IL45 Studien
- San Antonio, TX44 Studien
- Washington, DC43 Studien
- Dallas, TX42 Studien
- Seattle, WA39 Studien
Weitere Studien in St. Louis
- Nichtkleinzelliges Lungenkarzinom73 Studien
- Brustkrebs64 Studien
- Kolorektales Karzinom50 Studien
- Krebs (alle Arten)46 Studien
- Prostatakrebs46 Studien
- Lungenkrebs39 Studien
- Eierstockkrebs38 Studien
- Bauchspeicheldrüsenkrebs33 Studien
- Endometriumkarzinom29 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich28 Studien
- Herzinsuffizienz26 Studien
- Adipositas25 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.